Sudarshan Chemical Industries Limited has informed regarding Disclosure of material issue. Code of Conduct under Insider Trading
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical Industries' board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Standalone revenue from operations grew 18.3% to ₹2,533.9 crore, but standalone profit after tax fell to ₹140.97 crore from ₹335.12 crore a year ago because FY24 had a one-time ₹315 crore gain from sale of Pune land. Consolidated revenue jumped 31.8% to ₹3,345.6 crore, while consolidated PAT surged to ₹470.5 crore, boosted by an exceptional ₹1,243.9 crore bargain purchase gain from the completed Heubach Group pigment business acquisition in March 2025. Statutory auditors SRBC & Co LLP issued an unmodified opinion on standalone results but a modified (qualified) opinion on consolidated results, requiring a Statement of Impact on Audit Qualifications. The board recommended a final dividend of ₹4.50 per share (225% on face value of ₹2) subject to AGM approval, appointed a new secretarial auditor for five years, and approved a corporate guarantee of up to €25 million for subsidiary hedging needs.
Strong top-line growth and a transformational global acquisition are positive for long-term scale, but the modified audit opinion on consolidated results is a red flag shareholders should watch. The sharp decline in headline standalone PAT is largely a base-effect distortion from FY24's land sale, while the consolidated PAT jump is driven by a non-cash bargain purchase gain rather than core operations. The 225% dividend signals cash flow confidence but debt has risen sharply to fund the Heubach deal.